LCAR-B38M CAR-T cell injection
LCAR-B38M
Phase 2 mab active
Quick answer
LCAR-B38M CAR-T cell injection for Refractory or Relapsed Multiple Myeloma is a Phase 2 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Legend Biotech Corp
- Indication
- Refractory or Relapsed Multiple Myeloma
- Phase
- Phase 2
- Modality
- mab
- Status
- active